2020 Q2 Form 10-Q Financial Statement

#000119312520220348 Filed on August 14, 2020

View on sec.gov

Income Statement

Concept 2020 Q2
Revenue $17.88M
YoY Change
Cost Of Revenue $5.570M
YoY Change
Gross Profit $12.31M
YoY Change
Gross Profit Margin 68.84%
Selling, General & Admin $9.789M
YoY Change
% of Gross Profit 79.54%
Research & Development $2.400M
YoY Change
% of Gross Profit 19.5%
Depreciation & Amortization $20.00K
YoY Change
% of Gross Profit 0.16%
Operating Expenses $12.95M
YoY Change
Operating Profit -$641.0K
YoY Change
Interest Expense $27.56K
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$640.0K
YoY Change
Income Tax $6.000K
% Of Pretax Income
Net Earnings -$646.0K
YoY Change
Net Earnings / Revenue -3.61%
Basic Earnings Per Share
Diluted Earnings Per Share -$683.90
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.505M
YoY Change
Cash & Equivalents $32.02M
Short-Term Investments
Other Short-Term Assets $174.5K
YoY Change
Inventory
Prepaid Expenses $174.5K
Receivables
Other Receivables
Total Short-Term Assets $1.680M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $414.0M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $414.0M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.680M
Total Long-Term Assets $414.0M
Total Assets $415.7M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $76.67K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $301.7K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $14.49M
YoY Change
Total Long-Term Liabilities $14.49M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $301.7K
Total Long-Term Liabilities $14.49M
Total Liabilities $14.79M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$36.39K
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$87.35M
YoY Change
Total Liabilities & Shareholders Equity $415.7M
YoY Change

Cashflow Statement

Concept 2020 Q2
OPERATING ACTIVITIES
Net Income -$646.0K
YoY Change
Depreciation, Depletion And Amortization $20.00K
YoY Change
Cash From Operating Activities -$159.7K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $10.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$414.0M
YoY Change
Cash From Investing Activities -$414.0M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 415.7M
YoY Change
NET CHANGE
Cash From Operating Activities -159.7K
Cash From Investing Activities -414.0M
Cash From Financing Activities 415.7M
Net Change In Cash 1.505M
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$159.7K
Capital Expenditures $10.00K
Free Cash Flow -$169.7K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1505028
CY2020Q2 us-gaap Assets Current
AssetsCurrent
1679536
CY2020Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
414027563
CY2020Q2 us-gaap Assets
Assets
415707099
CY2020Q2 us-gaap Liabilities
Liabilities
14791666
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5035172
CY2020Q2 heccu Accrued Offering Costs
AccruedOfferingCosts
225000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
301666
CY2020Q2 heccu Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
14490000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-36385
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
5000003
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
415707099
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
62948
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
63948
CY2020Q2 heccu Interest Earned On Marketable Securities Held In Trust Account
InterestEarnedOnMarketableSecuritiesHeldInTrustAccount
27563
heccu Interest Earned On Marketable Securities Held In Trust Account
InterestEarnedOnMarketableSecuritiesHeldInTrustAccount
27563
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-35385
us-gaap Net Income Loss
NetIncomeLoss
-36385
heccu Interest Earned On Marketable Securities Held In Trust Account
InterestEarnedOnMarketableSecuritiesHeldInTrustAccount
27563
heccu Formation Costs Paid By Sponsor
FormationCostsPaidBySponsor
-2125
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
174508
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
76666
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-159665
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
414000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-414000000
us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
405720000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
10280000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
129606
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
415664693
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1505028
heccu Initial Classification Of Common Stock Subject To Possible Redemption
InitialClassificationOfCommonStockSubjectToPossibleRedemption
395946830
heccu Deferred Underwriting Fee Payables
DeferredUnderwritingFeePayables
14490000
heccu Deferred Offering Costs Paid Directly By Sponsor
DeferredOfferingCostsPaidDirectlyBySponsor
25000
CY2020Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10280000
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates </div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. </div></div><div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future events. Accordingly, the actual results could differ significantly from those estimates. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Concentration of Credit Risk </div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
76666
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-62948
us-gaap Operating Income Loss
OperatingIncomeLoss
-63948
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-35385
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-36385
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
205701
heccu Shares Subject To Possible Redemption Amount
SharesSubjectToPossibleRedemptionAmount
-31400
heccu Offering Costs Included In Accounts Payable
OfferingCostsIncludedInAccountsPayable
225000
dei Document Type
DocumentType
10-Q
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
174508
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
127481
us-gaap Payments For Underwriting Expense
PaymentsForUnderwritingExpense
8280000
heccu Under Writing Deferred Fee Per Unit
UnderWritingDeferredFeePerUnit
0.35
CY2020Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
41400000
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
39591543
CY2020Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
7600
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.00
CY2020Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
7600
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.00
CY2020Q2 heccu Franchise And Income Tax Expense
FranchiseAndIncomeTaxExpense
27000
heccu Franchise And Income Tax Expense
FranchiseAndIncomeTaxExpense
27000
CY2020Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2020Q2 heccu Other Offering Costs
OtherOfferingCosts
583182
CY2020Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2020Q2 us-gaap Cash
Cash
1505028
CY2020Q2 us-gaap Assets Held In Trust
AssetsHeldInTrust
414000000
CY2020Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.00
CY2020Q2 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.00
CY2020Q2 heccu Minimum Tangible Assets For Business Combination
MinimumTangibleAssetsForBusinessCombination
5000001
CY2020Q2 heccu Interest To Pay Dissolution Expenses
InterestToPayDissolutionExpenses
100000
CY2020Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.00
us-gaap Investment Income Interest
InvestmentIncomeInterest
0
heccu Under Writing Discount Per Unit Cash Paid
UnderWritingDiscountPerUnitCashPaid
0.20
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Shell Company
EntityShellCompany
true
dei Entity Registrant Name
EntityRegistrantName
Hudson Executive Investment Corp.
dei Entity Central Index Key
EntityCentralIndexKey
0001803901
dei Amendment Flag
AmendmentFlag
false
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-1000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
24000
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
390646818
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
10280000
CY2020Q2 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
395915430

Files In Submission

Name View Source Status
0001193125-20-220348-index-headers.html Edgar Link pending
0001193125-20-220348-index.html Edgar Link pending
0001193125-20-220348.txt Edgar Link pending
0001193125-20-220348-xbrl.zip Edgar Link pending
d23852d10q.htm Edgar Link pending
d23852dex311.htm Edgar Link pending
d23852dex312.htm Edgar Link pending
d23852dex321.htm Edgar Link pending
d23852dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
heccu-20200630.xml Edgar Link completed
heccu-20200630.xsd Edgar Link pending
heccu-20200630_cal.xml Edgar Link unprocessable
heccu-20200630_def.xml Edgar Link unprocessable
heccu-20200630_lab.xml Edgar Link unprocessable
heccu-20200630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending